Aggrelyte‐2 promotes protein solubility and decreases lens stiffness through lysine acetylation and disulfide reduction: Implications for treating presbyopia
Aging Cell · 2023
DOI: 10.1111/acel.13797 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2023. Verfasst von Sudipta Panja und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, School of Medicine, Sue Anschutz-Rodgers Eye Center, University of Colorado Anschutz Medical Campus, Colorado, Aurora, U…. Hauptthemen laut MEDLINE: Presbyopia, Lens, Crystalline, Crystallins. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Aging proteins in the lens become increasingly aggregated and insoluble, contributing to presbyopia. In this study, we investigated the ability of aggrelyte‐2 (N,S‐diacetyl‐L‐cysteine methyl ester) to reverse the water insolubility of aged human lens proteins and to decrease stiffness in cultured human and mouse lenses. Water‐insoluble proteins (WI) of aged human lenses (65–75 years) were incubated with aggrelyte‐2 (500 μM) for 24 or 48 h. A control compound that lacked the S‐acetyl group (aggrelyte‐2C) was also tested. We observed 19%–30% solubility of WI upon treatment with aggrelyte‐2. Aggrelyte‐2C also increased protein solubility, but its effect was approximately 1.4‐fold lower than that of aggrelyte‐2. The protein thiol contents were 1.9‐ to 4.9‐fold higher in the aggrelyte‐2‐ and aggrelyte‐2C‐treated samples than in the untreated samples. The LC–MS/MS results showed N ε ‐acetyllysine (AcK) levels of 1.5 to 2.1 nmol/mg protein and 0.6 to 0.9 nmol/mg protein in the aggrelyte‐2‐ and aggrelyte‐2C‐treated samples. Mouse (C57BL/6J) lenses (incubated for 24 h) and human lenses (incubated for 72 h) with 1.0 mM aggrelyte‐2 showed significant decreases in stiffness with simultaneous increases in soluble proteins (human lenses) and protein‐AcK levels, and such changes were not observed in aggrelyte‐2C‐treated lenses. Mass spectrometry of the solubilized protein revealed AcK in all crystallins, but more was observed in α‐crystallins. These results suggest that aggrelyte‐2 increases protein solubility and decreases lens stiffness through acetylation and disulfide reduction. Aggrelyte‐2 might be useful in treating presbyopia in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, School of Medicine, Sue Anschutz-Rodgers Eye Center, University of Colorado Anschutz Medical Campus, Colorado, Aurora, USA.
- Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
ORCID-Profile: Sudipta Panja, Ram H Nagaraj
Förderung
- NEI NIH HHS
- National Institutes of Health
Zitieren
APA
Panja, S., Nahomi, R. B., Rankenberg, J., Michel, C. R., Gaikwad, H., Nam, M. H., & Nagaraj, R. H. (2023). Aggrelyte‐2 promotes protein solubility and decreases lens stiffness through lysine acetylation and disulfide reduction: Implications for treating presbyopia. Aging Cell. https://doi.org/10.1111/acel.13797
Vancouver
Panja S, Nahomi RB, Rankenberg J, Michel CR, Gaikwad H, Nam MH, et al. Aggrelyte‐2 promotes protein solubility and decreases lens stiffness through lysine acetylation and disulfide reduction: Implications for treating presbyopia. Aging Cell. 2023. doi:10.1111/acel.13797
BibTeX
@article{Panja2023,
author = {Panja, Sudipta and Nahomi, Rooban B and Rankenberg, Johanna and Michel, Cole R and Gaikwad, Hanmant and Nam, Mi-Hyun and Nagaraj, Ram H},
title = {Aggrelyte‐2 promotes protein solubility and decreases lens stiffness through lysine acetylation and disulfide reduction: Implications for treating presbyopia},
journal = {Aging Cell},
year = {2023},
doi = {10.1111/acel.13797}
}
EUVIMED